Skip to main content
. 2018 Apr 23;19(4):1257. doi: 10.3390/ijms19041257

Table 1.

Percentage of variance of the data explained by PCA for the OP and their enantiomers.

Principal Components % of Variance % of Cumulative VARIANCE Principal Components % of Variance % of Cumulative VARIANCE
(RP)-Cyclosarin (SP)-Cyclosarin
PC1 50.05 50.05 PC1 47.55 47.55
PC2 16.24 66.29 PC2 21.32 68.87
PC3 14.82 81.11 PC3 12.88 81.75
PC4 10.23 91.34 PC4 8.98 90.73
PC5 5.75 97.09 PC5 5.98 96.71
PC6 2.81 99.90 PC6 3.21 99.92
PC7 0.09 99.99 PC7 0.07 99.99
PC8 0.01 100.00 PC8 0.01 100.00
(RP)-Soman (SP)-Soman
PC1 44.64 44.64 PC1 49.92 49.92
PC2 14.68 59.32 PC2 19.94 69.87
PC3 13.48 72.80 PC3 12.13 82.00
PC4 11.63 84.43 PC4 10.64 92.64
PC5 6.83 91.26 PC5 6.07 98.71
PC6 5.25 96.51 PC6 1.25 99.96
PC7 3.43 99.94 PC7 0.03 99.99
PC8 0.06 100.00 PC8 0.01 100.00
(RP)-Tabun (SP)-Tabun
PC1 38.25 38.25 PC1 36.08 36.08
PC2 23.89 62.14 PC2 22.48 58.56
PC3 16.22 78.36 PC3 15.66 74.22
PC4 12.95 91.30 PC4 11.39 85.61
PC5 5.90 97.20 PC5 8.83 94.44
PC6 2.60 99.80 PC6 5.34 99.78
PC7 0.19 99.99 PC7 0.13 99.91
PC8 0.01 100.00 PC8 0.09 100.00